COSCIENS Biopharma Overview
- Year Founded
-
1990
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
PIPE
- Financing Rounds
-
8
- Investments
-
5
COSCIENS Biopharma General Information
Description
AEterna Zentaris Inc. is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland which generates key revenue, Ireland, Denmark, and others.
Contact Information
Website
www.cosciensbio.comCorporate Office
- 22 Adelaide Street West
- Suite 3400
- Toronto, Ontario M5H 4E3
- Canada
Corporate Office
- 22 Adelaide Street West
- Suite 3400
- Toronto, Ontario M5H 4E3
- Canada
COSCIENS Biopharma Comparisons
Industry
Financing
Details
COSCIENS Biopharma Competitors (23)
One of COSCIENS Biopharma’s 23 competitors is Evonile Pharma, a Private Equity-Backed company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| RaQualia Pharma | Formerly PE-Backed | Nagoya, Japan | ||||
| China Resources Pharmaceutical Group | Corporation | Hong Kong, Hong Kong | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| Novartis | Corporation | Basel, Switzerland |
COSCIENS Biopharma Patents
COSCIENS Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020460118-A1 | A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin | Active | 22-Jul-2020 | ||
| AU-2020460118-B2 | A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin | Active | 22-Jul-2020 | ||
| CA-3185680-A1 | A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin | Pending | 22-Jul-2020 | ||
| EP-4185866-A1 | A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin | Pending | 22-Jul-2020 | ||
| WO-2022017599-A1 | A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin | Inactive | 22-Jul-2020 | G01N33/74 |
COSCIENS Biopharma Signals
COSCIENS Biopharma Exits (1)
COSCIENS Biopharma’s most recent exit was on 06-Jan-2005 from Echelon Biosciences. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Echelon Biosciences | 06-Jan-2005 | Completed |
|
COSCIENS Biopharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Nualtis | Saint-Laurent, Canada | 2003 |
COSCIENS Biopharma FAQs
-
When was COSCIENS Biopharma founded?
COSCIENS Biopharma was founded in 1990.
-
Where is COSCIENS Biopharma headquartered?
COSCIENS Biopharma is headquartered in Toronto, Canada.
-
What is the size of COSCIENS Biopharma?
COSCIENS Biopharma has 24 total employees.
-
What industry is COSCIENS Biopharma in?
COSCIENS Biopharma’s primary industry is Pharmaceuticals.
-
Is COSCIENS Biopharma a private or public company?
COSCIENS Biopharma is a Private company.
-
What is COSCIENS Biopharma’s current revenue?
The current revenue for COSCIENS Biopharma is .
-
How much funding has COSCIENS Biopharma raised over time?
COSCIENS Biopharma has raised $90.4M.
-
Who are COSCIENS Biopharma’s competitors?
Evonile Pharma, RaQualia Pharma, China Resources Pharmaceutical Group, Roche, and Novartis are some of the 23 competitors of COSCIENS Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process